HUMANIGEN INC - COM NEW (HGEN)

CUSIP: 444863203

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM NEW
Total 13F shares
7,132,116
Share change
-14,738,315
Total reported value
$1,283,288
Put/Call ratio
0%
Price per share
$0.18
Number of holders
38
Value change
-$27,470,236
Number of buys
21
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 444863203?
CUSIP 444863203 identifies HGEN - HUMANIGEN INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HUMANIGEN INC - COM NEW (HGEN) as of Q3 2022

As of 30 Sep 2022, HUMANIGEN INC - COM NEW (HGEN) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,132,116 shares. The largest 10 holders included GSA CAPITAL PARTNERS LLP, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Bank of New York Mellon Corp, GEODE CAPITAL MANAGEMENT, LLC, Telemetry Investments, L.L.C., MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, and CITADEL ADVISORS LLC. This page lists 38 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.